Contact this trialFirst, we need to learn more about you.
Dopamine Agonist
CVN424 for Parkinson's Disease
Recruiting1 awardPhase 3
Memphis, Tennessee
This trial is testing a new medication for Parkinson's disease. Participants will be randomly assigned to take either the new medication at two different doses or a placebo for 12 weeks. If they complete the study
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service